{'https:': 2609, '': 2776, 'www.novartis.com': 278, '#main': 7, 'content': 26, 'javascript:void(0)': 3, '#international': 2, '#americas': 2, '#asia': 2, 'pacific': 2, '#europe': 2, '#middle': 2, 'east': 2, 'africa': 5, 'www.sandoz.com': 4, 'www.novartisfoundation.org': 3, 'www.novartis.com.ar': 2, 'www.novartis.com.br': 2, 'www.novartis.ca': 4, 'en': 301, 'fr': 11, 'www.cac.novartis.com': 2, 'www.novartis.com.co': 2, 'www.novartis.com.mx': 2, 'www.novartis.us': 2, 'www.novartis.com.ve': 2, 'www.novartis.com.au': 2, 'www.novartis.com.bd': 2, 'www.novartis.com.hk': 2, 'www.novartis.in': 2, 'www.id.novartis.com': 2, 'www.novartis.co.jp': 2, 'www.novartis.co.kr': 2, 'www.novartis.com.cn': 2, 'my': 4, 'pk': 2, 'ph': 2, 'www.novartis.com.sg': 2, 'www.novartis.com.tw': 2, 'www.novartis.at': 2, 'www.novartis.be': 4, 'nl': 5, 'www.novartis.bg': 2, 'www.novartis.cz': 4, 'cs': 2, 'www.novartis.dk': 2, 'www.novartis.ee': 2, 'www.novartis.fi': 2, 'www.novartis.fr': 2, 'www.novartis.de': 2, 'www.novartis.gr': 2, 'www.novartis.hu': 2, 'www.novartis.ie': 2, 'www.novartis.it': 2, 'www.novartis.lv': 2, 'www.novartis.lt': 2, 'www.novartis.nl': 2, 'www.novartis.no': 2, 'www.novartis.pl': 2, 'www.novartis.pt': 2, 'www.novartis.com.ro': 2, 'www.novartis.ru': 2, 'www.novartis.rs': 2, 'www.novartis.sk': 2, 'www.novartis.es': 2, 'www.novartis.se': 2, 'www.novartis.ch': 4, 'de': 4, 'www.novartis.co.uk': 2, 'www.novartis.com.eg': 2, 'www.novartis.co.il': 2, 'www.novartis.co.za': 2, 'www.novartis.com.tr': 2, 'None': 96, 'about': 210, 'board': 27, 'directors': 24, 'joerg': 1, 'reinhardt': 1, 'simon': 1, 'moroney': 1, 'nancy': 1, 'andrews': 1, 'ton': 1, 'buechner': 1, 'patrice': 1, 'bula': 1, 'elizabeth': 1, 'doherty': 1, 'ana': 1, 'pro': 1, 'gonzalo': 1, 'bridgette': 1, 'heller': 1, 'daniel': 1, 'hochstrasser': 1, 'frans': 1, 'van': 1, 'houten': 1, 'andreas': 1, 'von': 1, 'planta': 1, 'charles': 1, 'sawyers': 1, 'william': 1, 'winters': 1, 'charlotte': 1, 'pamer': 1, 'wieser': 1, 'executive': 16, 'committee': 16, 'vasant': 1, 'narasimhan': 1, 'shreeram': 1, 'aradhye': 1, 'victor': 1, 'bulto': 1, 'aharon': 1, 'ronny': 1, 'gal': 1, 'phd': 1, 'karen': 1, 'hale': 1, 'harry': 1, 'kirsch': 1, 'rob': 1, 'kowalski': 1, 'steffen': 1, 'lang': 1, 'fiona': 1, 'marshall': 1, 'klaus': 1, 'moosmayer': 1, 'marie': 1, 'france': 3, 'tschudin': 1, 'lutz': 1, 'hegemann': 1, 'kees': 1, 'roks': 1, 'richard': 1, 'saynor': 1, 'michael': 5, 'willi': 1, 'strategy': 23, 'people': 34, 'and': 289, 'culture': 10, 'data': 37, 'digital': 12, 'products': 58, 'innovative': 3, 'medicines': 18, 'diversity': 27, 'equity': 23, 'inclusion': 19, 'governance': 38, 'community': 19, 'inclusivity': 1, 'parental': 1, 'leave': 1, 'society': 10, 'manufacturing': 20, 'quality': 16, 'audit': 1, 'program': 18, 'novartis': 40, 'management': 7, 'system': 1, 'qms': 1, 'product': 9, 'patient': 43, 'safety': 28, 'training': 2, 'regulatory': 1, 'inspections': 1, 'recalls': 1, 'third': 2, 'party': 1, 'suppliers': 5, 'awards': 3, 'recognition': 2, 'patients': 45, 'caregivers': 10, 'commitment': 7, 'diseases': 16, 'esg': 42, 'reporting': 29, 'transparency': 10, 'disclosure': 3, 'organization': 2, 'funding': 2, 'coronavirus': 21, 'news': 133, 'stories': 109, 'perspectives': 3, 'healthcare': 31, 'professionals': 30, 'medical': 18, 'congresses': 4, 'events': 34, 'abstract': 3, 'summaries': 4, 'eular': 1, 'acr': 1, 'eadv': 1, 'research': 75, 'development': 54, 'pipeline': 72, 'managed': 3, 'access': 32, 'programs': 15, 'gene': 3, 'therapies': 1, 'external': 1, 'professional': 1, 'resources': 17, 'country': 1, 'investigator': 2, 'initiated': 2, 'trials': 61, 'studies': 3, 'information': 62, 'submit': 2, 'enquiry': 1, 'institutes': 4, 'biomedical': 3, 'collaborations': 2, 'nibr': 2, 'global': 52, 'scholars': 1, 'technology': 20, 'platforms': 8, 'radioligand': 1, 'therapy': 4, 'cell': 6, 'disease': 62, 'areas': 68, 'immuno': 1, 'oncology': 10, 'cardiovascular': 8, 'metabolic': 1, 'autoimmunity': 1, 'transplantation': 1, 'inflammatory': 2, 'ophthalmology': 1, 'neuroscience': 6, 'musculoskeletal': 1, 'dax': 1, 'exploratory': 1, 'locations': 31, 'institute': 1, 'tropical': 1, 'translational': 1, 'medicine': 22, 'approach': 2, 'open': 2, 'source': 2, 'science': 260, 'from': 11, 'our': 89, 'labs': 1, 'creating': 1, 'sustainable': 1, 'business': 10, 'models': 1, 'value': 4, 'based': 1, 'pricing': 6, 'sub': 3, 'saharan': 3, 'donations': 1, 'principles': 6, 'patents': 1, 'licensing': 1, 'ethics': 11, 'risk': 11, 'compliance': 14, 'ethical': 13, 'behavior': 1, 'human': 7, 'rights': 6, 'learning': 6, 'engagement': 6, 'environmental': 25, 'sustainability': 24, 'climate': 6, 'waste': 2, 'water': 2, 'health': 36, 'anti': 8, 'microbial': 1, 'resistance': 1, 'amr': 1, 'avoidable': 1, 'blindness': 1, 'chagas': 1, 'leprosy': 1, 'malaria': 1, 'sickle': 1, 'rating': 1, 'performance': 2, 'codes': 2, 'policies': 18, 'guidelines': 2, 'materiality': 1, 'assessment': 1, 'targets': 1, 'positions': 5, 'index': 3, 'social': 20, 'investors': 114, 'event': 3, 'calendar': 3, 'financial': 27, 'annual': 24, 'results': 18, 'quarterly': 7, 'sec': 9, 'filings': 8, 'sales': 4, 'fixed': 1, 'income': 1, 'securities': 3, 'expected': 1, 'currency': 1, 'impact': 6, 'share': 27, 'analysis': 6, 'monitor': 1, 'dividend': 12, 'ownership': 1, 'overview': 6, 'return': 1, 'investment': 4, 'calculator': 1, 'shareholder': 22, 'general': 5, 'meetings': 1, 'american': 3, 'depository': 1, 'receipts': 1, 'adr': 2, 'buy': 1, 'back': 1, 'frequently': 2, 'asked': 2, 'questions': 2, 'company': 78, 'corporate': 32, 'suite': 2, 'archive': 6, 'stay': 2, 'up': 5, 'to': 75, 'date': 2, 'media': 45, 'library': 2, 'careers': 145, 'career': 10, 'search': 4, 'teams': 16, 'commercial': 1, 'communications': 1, 'consulting': 1, 'environment': 7, 'it': 3, 'procurement': 1, 'supply': 6, 'erc': 1, 'legal': 24, 'exploration': 1, 'lab': 1, 'postdoc': 2, 'early': 16, 'talent': 17, 'us': 82, 'internship': 1, 'international': 1, 'personal': 1, 'growth': 1, 'well': 2, 'being': 2, 'clinicaltrials': 4, 'partnering': 12, 'supplier': 7, 'portal': 2, 'report': 9, 'contacts': 9, 'home': 4, '#paragraph': 4, '2146': 2, 'releases': 62, 'announces': 15, 'appointment': 1, 'chairman': 1, 'designate': 1, 'sandoz': 3, 'biologics': 3, 'license': 1, 'application': 1, 'proposed': 1, 'biosimilar': 7, 'denosumab': 1, 'accepted': 1, 'fda': 1, 'hidradenitis': 1, 'suppurativa': 1, 'experienced': 12, 'sustained': 1, 'efficacy': 3, 'symptom': 1, 'improvement': 1, 'one': 7, 'year': 13, 'when': 1, 'treated': 1, 'cosentyx': 1, '2022': 21, 'spinoff': 1, 'www.reporting.novartis.com': 2, 'in': 52, 'society.html': 2, '95946': 2, 'compassionate': 2, 'use': 12, 'providing': 1, 'much': 1, 'needed': 1, 'treatments': 1, 'www.adacap.com': 1, 'www.gyroscopetx.com': 1, 'www.twitter.com': 4, 'www.linkedin.com': 27, 'www.youtube.com': 10, 'user': 6, 'www.facebook.com': 10, 'www.instagram.com': 10, 'terms': 14, 'privacy': 109, '#cookie': 1, 'settings': 1, 'button': 1, 'sitemap.xml': 1, 'accessibility': 3, 'directory': 1, 'www.onetrust.com': 1, 'cookie': 15, 'consent': 1, 'www.janssen.com': 139, '#': 90, 'covid': 8, '19': 9, 'vaccine': 16, 'es': 2, 'ja': 1, 'pt': 2, 'ko': 2, 'ru': 2, '#search': 1, 'contact': 64, 'grants': 9, 'giving': 3, 'blogs': 3, 'leadership': 16, 'metabolism': 1, 'retina': 1, 'immunology': 6, 'infectious': 11, 'vaccines': 5, 'pulmonary': 1, 'hypertension': 1, 'explore': 1, 'covid19': 2, 'clinical': 68, 'pre': 6, 'approval': 1, 'janssen': 5, 'rnd': 2, 'http:': 99, 'www.globaltrialfinder.janssen.com': 1, 'world': 12, 'without': 1, 'accelerator': 1, 'partnerships': 12, 'precision': 7, 'diagnostics': 1, '0': 3, 'generationcare': 1, 'generation': 1, 'care': 1, 'jrd': 1, 'menu': 1, 'apac': 1, 'australia': 2, 'www.xian': 1, 'janssen.com.cn': 1, 'hongkong': 2, 'zh': 1, 'hant': 1, 'india': 1, 'japan': 1, 'korea': 1, 'newzealand': 1, 'emea': 1, 'austria': 2, 'belgium': 3, 'bulgaria': 1, 'croatia': 1, 'czech': 1, 'denmark': 1, 'estonia': 1, 'finland': 1, 'germany': 2, 'greece': 1, 'hungary': 1, 'ireland': 4, 'israel': 1, 'italy': 3, 'latvia': 1, 'lithuania': 1, 'netherlands': 1, 'norway': 1, 'poland': 2, 'portugal': 2, 'romania': 1, 'russia': 1, 'serbia': 1, 'slovakia': 1, 'slovenia': 1, 'southafrica': 1, 'spain': 2, 'sweden': 1, 'switzerland': 2, 'turkey': 1, 'uk': 2, 'latinoamerica': 1, 'argentina': 1, 'bolivia': 1, 'brasil': 1, 'centralamericaandthecaribbean': 2, 'chile': 1, 'colombia': 1, 'ecuador': 1, 'mexico': 1, 'paraguay': 1, 'peru': 1, 'uruguay': 1, 'canada': 3, 'www.jnj.com': 2, 'latest': 2, 'johnson': 6, 'named': 1, 'a': 29, '2023': 53, 'fortune': 1, 'worlds': 1, 'most': 1, 'admired': 1, 'support': 15, 'twitter.com': 100, 'JanssenGlobal': 2, 'channel': 2, 'UCHOwWxMVtei89ur1JxMvOdA': 2, 'pharmaceutical': 3, 'companies': 6, 'of': 80, 'janssenglobal': 2, 'policy': 30, 'notice': 16, 'www.amgen.com': 301, 'sharethis.com': 1, 'policies.google.com': 25, 'www.cookiebot.com': 4, 'goto': 2, 'www.salesforce.com': 8, 'www.cision.com': 2, '?nav_location=footer': 2, 'www.iheart.com': 12, 'www.podbean.com': 5, 'vimeo.com': 2, 'privacy.microsoft.com': 14, 'privacystatement': 14, 'www.tiktok.com': 6, 'policy?lang=en': 6, 'www.adobe.com': 1, 'privacy.html': 1, 'www.oracle.com': 3, 'addthis': 3, 'policy.html': 5, 'US': 5, 'www.outbrain.com': 1, 'privacy#privacy': 1, 'www.stackadapt.com': 4, 'www.brightcove.com': 1, 'www.mediamath.com': 1, 'omnystudio.com': 1, 'amgen': 55, 'history': 16, 'mission': 13, 'values': 4, 'www.amgenfoundation.org': 2, 'accolades': 2, 'how': 28, 'we': 42, 'operate': 11, 'responsibility': 123, 'healthy': 42, 'practices': 6, 'disclosures': 8, 'www.amgenpipeline.com': 2, 'podcasts': 3, 'scientific': 26, 'advisory': 3, 'boards': 2, 'www.amgenscientificgrants.com': 2, 'www.amgenbiosimilars.com': 2, 'www.amgentrials.com': 2, 'trial': 9, 'for': 26, 'out': 2, 'hours': 2, 'www.amgeniss.com': 2, 'initiatives': 11, 'educational': 7, 'outreach': 2, 'postdoctoral': 3, 'fellows': 4, 'conferences': 3, 'start': 2, 'network': 2, 'innovation': 86, 'reliability': 2, 'www.amgenmedinfo.com': 2, 'counterfeit': 2, 'drug': 10, 'statement': 6, 'sheets': 6, 'who': 26, 'are': 33, 'what': 2, 'do': 3, 'adverse': 2, 'capital': 2, 'partners': 15, 'planet': 7, 'conduct': 2, 'cybersecurity': 2, 'metrics': 9, 'summary': 2, 'cdp': 2, 'archived': 2, 'reports': 22, 'categories': 26, 'stories?tag=COVID': 3, 'stories?tag=Supporting%20Our%20Staff': 3, 'stories?tag=Leveraging%20Our%20Science': 3, 'stories?tag=Serving%20Our%20Communities': 3, 'newsroom': 34, 'investors.amgen.com': 3, 'careers.amgen.com': 3, 'worldwide': 4, 'Amgen': 2, 'amgenbiotech': 4, 'ai': 3, 'multispecifics': 1, 'other': 5, 'modalities': 1, '02': 30, 'heart': 6, 'studys': 2, 'goal': 2, 'better': 4, 'understand': 2, 'serve': 5, 'the': 81, 'underrepresented': 2, 'wwwext.amgen.com': 10, 'press': 40, 'study': 26, 'evaluate': 3, 'association': 3, 'between': 3, 'lipoproteina': 5, 'african': 3, 'americans': 6, 'origins': 2, 'single': 5, 'arm': 2, 'that': 2, 'relieved': 2, 'many': 2, 'backs': 2, 'foundation': 14, 'donates': 2, 'relief': 4, 'efforts': 8, 'turkiye': 2, 'syria': 2, 'following': 2, 'earthquake': 2, '5': 6, 'things': 4, 'you': 2, 'need': 2, 'know': 4, 'attacks': 2, '8': 3, 'howard': 2, 'university': 2, 'students': 4, 'finish': 2, 'with': 39, 'new': 20, 'skills': 2, 'outlook': 2, 'on': 12, 'paths': 2, 'cancer': 3, 'day': 3, 'around': 3, 'invests': 3, '$150': 3, 'million': 7, 'fund': 3, 'scale': 3, 'minority': 3, 'owned': 3, 'businesses': 3, 'tezspire': 5, 'approved': 5, 'self': 5, 'administration': 5, 'u': 5, 's': 12, 'filled': 5, 'pen': 5, '01': 17, 'fourth': 9, 'quarter': 9, 'full': 14, 'common': 3, 'operations': 6, 'shine': 3, 'launch': 3, 'amjevita': 3, 'adalimumabatto': 3, 'first': 4, 'humira': 3, 'now': 3, 'available': 3, 'united': 8, 'states': 4, 'leaders': 11, 'advocacy': 5, 'accomplishments': 3, 'aspirations': 3, 'collaborating': 4, 'address': 3, 'moderate': 3, 'severe': 4, 'atopic': 3, 'dermatitis': 3, 'knowkras': 3, 'stories?tag=KRAS%20G12C': 1, 'present': 5, 'at': 19, 'svb': 2, 'biopharma': 10, 'conference': 11, 'posts': 2, 'transcript': 2, 'audio': 2, 'replay': 2, 'earnings': 2, 'webcast': 2, 'ukrainian': 1, 'refugee': 1, '2020': 18, '12': 9, 'recipients': 3, '25m': 3, 'justice': 9, 'equal': 6, 'opportunity': 7, 'joins': 3, 'coalition': 3, 'hire': 7, 'black': 3, 'over': 3, '10': 7, 'years': 3, '05': 3, 'ceo': 6, 'bob': 3, 'bradway': 3, 'shares': 4, 'perspective': 3, 'death': 3, 'george': 3, 'floyd': 3, '06': 3, '7': 4, '5m': 3, 'racial': 4, 'coming': 3, 'together': 13, 'advance': 3, '11': 5, 'conversation': 3, 'amgens': 3, 'echoing': 3, 'greens': 3, 'president': 3, 'sitemap': 3, 'javascript:Cookiebot.renew()': 1, 'www.pfizer.com': 155, 'guide': 1, 'children': 1, 'integrity': 5, 'plain': 1, 'language': 1, 'expanded': 3, 'www.pfizerclinicaltrials.com': 1, 'find': 1, 'focus': 26, 'rare': 3, 'internal': 3, 'inflammation': 3, 'infectives': 3, 'medicinal': 1, 'sciences': 3, 'maternal': 1, 'immunization': 1, 'mrna': 2, 'conditions': 1, 'centers': 1, 'drugs': 10, 'made': 10, 'branded': 2, 'versus': 2, 'generics': 2, 'biosimilars': 2, 'sites': 2, 'literacy': 1, 'treatment': 9, 'choices': 1, 'tips': 1, 'counterfeiting': 1, 'list': 1, 'www.pfizerpro.com': 2, 'www.pfizerrxpathways.com': 1, 'distributors': 2, 'pfizer': 6, 'greenstone': 1, 'articles': 5, 'announcements': 9, 'behind': 30, 'stories#ebooks': 1, 'section': 7, 'assets': 1, 'updates': 1, 'statements': 1, 'relation': 1, 'executives': 1, 'members': 1, 'scientists': 1, 'colleagues': 1, 'ehs': 1, 'intellectual': 1, 'property': 1, 'putting': 1, 'political': 1, 'working': 3, 'prescription': 1, 'ready': 1, 'cures': 1, 'investors.pfizer.com': 14, 'default.aspx': 12, 'why': 7, 'invest': 5, 'story': 3, 'presentations': 11, 'financials': 1, 'investor': 5, 'stock': 26, 'historical': 1, 'chart': 3, 'services': 3, 'committees': 2, 'charters': 1, 'faqs': 5, 'pfizer.wd1.myworkdayjobs.com': 1, 'PfizerCareers': 1, 'growth_development': 1, 'connect': 1, 'venture': 2, 'investments': 1, 'B2B': 2, 'centreone': 1, 'your': 4, 'opportunities': 6, 'trachoma': 1, 'initiative': 1, 'science#scienceWillWinVideo': 1, 'three_principles_of_responsibility_for_artificial_intelligence_ai_in_healthcare': 1, '5_inspiring_stem_women_who_are_making_medicine_happen': 1, 'a_billion_doses_delivered_3_lessons_from_the_fight_against_trachoma': 1, 'prevention': 3, 'options': 3, 'spanish': 3, 'speakers': 3, 'supporting': 3, 'fight': 3, 'pfizerretailstore.mypromomall.com': 1, 'pfizerretailstore': 1, 'Privacy': 1, 'Pfizer': 3, 'pfizerinc': 1, 'www.gsk.com': 276, 'gb': 274, '#header': 1, 'www.gskpro.com': 3, 'magazine': 28, 'purpose': 22, 'outstanding': 15, 'gsk': 14, 'innovating': 7, '2021': 5, 'glance': 1, 'heritage': 1, 'team': 5, 'shareholders': 3, 'sarbanes': 1, 'oxley': 1, 'act': 2, '2002': 1, 'standards': 11, 'therapeutic': 13, 'hiv': 2, 'driven': 1, 'technologies': 1, 'provision': 1, 'unlicensed': 1, 'unmet': 2, 'needs': 2, 'supported': 1, 'rd': 10, 'z': 1, 'gskpro.com': 1, 'security': 8, 'using': 6, 'improving': 1, 'materials': 1, 'biodiversity': 1, 'parties': 1, 'public': 6, 'animals': 1, 'engaging': 1, 'charitable': 1, 'speeches': 1, 'price': 12, 'calculators': 4, 'gbpusd': 4, 'exchange': 6, 'london': 3, 'rns': 2, 'inside': 1, 'york': 1, 'sign': 1, 'analyst': 10, 'consensus': 1, 'manage': 1, 'meeting': 3, 'sponsored': 1, 'nominee': 1, 'service': 1, 'programme': 9, 'asset': 1, 'reunification': 1, 'prosearch': 1, 'scam': 1, 'alert': 1, 'ordinary': 1, 'actions': 5, 'consumer': 2, 'demerger': 1, 'joint': 1, 'agreement': 1, 'acquire': 1, 'tesaro': 1, 'debt': 1, 'details': 20, 'response': 5, 'situation': 1, 'ukraine': 1, 'rss': 1, 'feeds': 1, 'jobs': 1, 'featured': 3, 'renal': 1, 'life': 17, 'engineering': 3, 'marketing': 2, 'chemical': 2, 'controls': 1, 'cmc': 1, 'mds': 1, 'genomic': 1, 'kickstart': 1, 'apprentice': 1, 'programmes': 1, 'work': 1, 'experience': 1, 'placements': 1, 'internships': 2, 'future': 8, 'graduate': 9, 'logistics': 1, 'post': 1, 'regional': 3, 'hubs': 3, 'fraudulent': 1, 'internet': 2, 'recruitment': 1, 'activities': 1, 'fresh': 4, 'insights': 4, 'could': 4, 'finally': 4, 'help': 5, 'tackle': 4, 'rsv': 7, 'getting': 3, 'ahead': 3, 'advanced': 6, 'tech': 5, 't': 3, 'cells': 6, 'rna': 3, 'seq': 3, 'measures': 3, 'shifts': 3, 'immune': 11, 'pinpoint': 3, 'causes': 3, 'tripledemic': 3, 'flu': 3, 'older': 3, 'ml': 2, 'power': 4, 'predictions': 2, 'twin': 2, 'accelerate': 2, 'maps': 3, 'age': 2, 'combining': 3, 'genetics': 4, 'double': 2, 'success': 2, 'rates': 2, '8520': 1, 'code': 2, 'presentation': 5, 'version.pdf': 1, '#meet': 6, 'kumaran:': 1, 'develop': 2, 'meg:': 1, 'more': 2, 'katie:': 1, 'big': 1, 'nancy:': 1, 'igniting': 1, 'change': 1, '&': 1, 'living': 3, 'respiratory': 1, 'syncytial': 1, 'virus': 1, '(rsv)': 1, 'pal:': 1, 'genomics': 1, 'doug:': 1, 'inform': 1, 'gsks': 1, 'decisions': 1, '#1': 1, '#2': 1, '#3': 1, '#4': 1, '#5': 1, '#6': 1, 'delivers': 1, 'strong': 1, '293': 1, 'billion': 1, 'headquarters': 1, 'central': 1, 'tops': 1, 'atmi': 1, 'eighth': 1, 'consecutive': 1, 'time': 1, 'hashtag': 40, 'RSV?src=hash': 8, 't.co': 12, '7k1haQoq3a': 2, 'GSK': 17, 'COVID19?src=hash': 5, 'Pki7smDKf4': 2, 'News?src=hash': 2, 'Investors?src=hash': 2, 'Media?src=hash': 2, 'ViiVHC': 4, 'CROI2023?src=hash': 2, '8z9eFhfDRj': 2, 'flu?src=hash': 3, 'tripledemic?src=hash': 3, 'LL4AsijkHt': 2, 'kFJoeazKgd': 1, 'DYK?src=hash': 1, 'OvarianCancer?src=hash': 1, 'HIV?src=hash': 1, 'CROI?src=hash': 1, '7vYgXYHz6g': 1, 'YxY54PjBD5': 1, 'NFIDVaccines': 1, 'OknN4rxAtc': 1, 'BehindTheScience?src=hash': 1, '7459': 1, 'modern': 1, 'slavery': 1, '2021.pdf': 1, 'www.gsk': 1, 'studyregister.com': 1, 'supplier.gsk.com': 1, 'viivhealthcare.com': 1, 'possible': 1, 'side': 1, 'effect': 1, 'gsk.i': 1, 'sight.com': 1, 'landing': 2, 'page': 2, 'glaxosmithkline': 1, 'privacy.gsk.com': 1, 'www.biogen.com': 110, 'cookies.html': 2, 'home.html': 4, 'innovation.html': 2, 'areas.html': 4, 'amyotrophic': 2, 'lateral': 2, 'sclerosis.html': 4, 'alzheimers': 15, 'disease.html': 2, 'depression': 5, 'postpartum': 3, 'depression.html': 3, 'lupus.html': 2, 'multiple': 2, 'spinal': 2, 'muscular': 2, 'atrophy.html': 2, 'stroke.html': 2, 'biosimilars.html': 1, 'expertise.html': 1, 'pipeline.html': 8, 'trials.html': 3, 'programs.html': 3, 'manufacturing.html': 1, 'biogen': 18, 'health.html': 2, 'about.html': 2, 'portfolio.html': 2, 'partnering.html': 2, 'cabinet.html': 1, 'medicines.html': 1, 'responsibility.html': 2, 'equity.html': 1, 'inclusion.html': 4, 'environment.html': 1, 'lives.html': 4, 'lab.html': 2, 'principles.html': 4, '20': 2, 'company.html': 1, 'elements.html': 1, 'leadership.html?tag=leadership': 1, 'leadership.html?tag=board': 1, 'foundation.html': 3, 'giving.html': 2, 'us.html': 10, 'connecting': 1, 'dots': 1, 'neuroscience.html': 2, 'careers.html': 3, 'search.html': 2, 'biogen.html': 1, 'hire.html': 1, 'categories.html': 1, 'graduates.html': 1, 'join.smartrecruiters.com': 1, 'Biogen': 2, '5e07e06a': 1, '6b73': 1, '4b1d': 1, '958f': 1, 'e3e704a6bb4b': 1, 'therese': 1, 'sabbatical.html': 1, 'investors.biogen.com': 9, 'ar.biogen.com': 1, 'br.biogen.com': 1, 'www.biogen.ca': 1, 'www.biibcolombia.co': 1, 'www.biogen.com.mx': 1, 'www.biogen.uy': 1, 'www.biogen.com.au': 1, 'www.biogen.cn': 1, 'www.biogen.co.jp': 1, 'www.biogen.co.nz': 1, 'kr.biogen.com': 1, 'www.biogen.tw': 1, 'www.biogen.at': 1, 'www.biogen.be': 1, 'www.biogen.hr': 1, 'www.biogen.com.cz': 1, 'www.biogen.dk': 1, 'www.biogen.ee': 1, 'www.biogen.fi': 1, 'www.biogen.fr': 1, 'www.biogen.de': 1, 'www.biogen.hu': 1, 'www.biogen.ie': 1, 'www.biogenitalia.it': 1, 'www.biogen.lv': 1, 'www.biogen.lt': 1, 'www.biogen.nl': 1, 'www.biogen.no': 1, 'www.biogen': 4, 'poland.pl': 1, 'www.biogen.pt': 1, 'www.biogen.sk': 1, 'pharma.si': 1, 'www.biogen.com.es': 1, 'www.biogen.se': 1, 'www.biogen.ch': 1, 'www.biogen.uk.com': 1, 'sa.com': 1, 'gulf.com': 1, 'international.html': 2, 'stories.html': 6, 'parkinsons': 8, 'alison': 2, 'story.html': 2, 'challenges': 2, 'diagnosis.html': 2, 'cutting': 2, 'edge': 2, 'science.html': 5, 'newsletter': 2, 'signup.html': 2, 'professionals.html': 2, 'review.html': 2, 'conditions.html': 1, 'center.html': 2, 'center': 38, 'california': 1, 'forward': 1, 'looking': 1, 'statements.html': 1, 'guidelines.html': 1, 'youtube.com': 1, 'www.abbvie.com': 139, '#maincontent': 1, 'views.html': 2, 'operating': 5, 'integrity.html': 1, 'protecting': 2, 'workplace': 1, 'safety.html': 2, 'payment.html': 1, 'responsible': 1, 'chain.html': 1, 'abbvies': 1, 'conduct.html': 1, 'key': 3, 'facts.html': 1, 'leaders.html': 3, 'disclosures.html': 2, 'data.html': 1, 'equality': 3, 'diversity.html': 1, 'through': 2, 'justice.html': 1, 'are.html': 2, 'impact.html': 2, 'voices': 1, 'abbvie': 28, 'reflecting': 1, 'decade': 1, 'focus.html': 1, 'immunology.html': 1, 'oncology.html': 1, 'eye': 2, 'care.html': 1, 'aesthetics.html': 1, 'convergence.html': 1, 'genomics.html': 1, 'focused': 1, 'development.html': 3, 'medicine.html': 1, 'modalities.html': 1, 'technologies.html': 1, 'publications.html': 1, 'partner': 13, 'days.html': 1, 'ventures.html': 1, 'studies.html': 1, 'sites.html': 1, 'independent': 7, 'grants.html': 1, 'apply.html': 1, 'request': 3, 'types.html': 1, 'requestor': 1, 'guide.html': 1, 'contribution': 1, 'support.html': 4, 'assistance.html': 2, 'products.html': 4, 'patients.html': 2, 'dam': 5, 'com2': 5, 'pdfs': 5, 'medicines.pdf': 2, 'an': 2, 'illness.html': 1, 'join': 15, 'opportunities.html': 1, 'program.html': 1, 'student': 1, 'abbvie.html': 3, 'benefits.html': 2, 'workplace.html': 1, 'employee': 2, 'resource': 1, 'groups.html': 1, 'careers.abbvie.com': 2, 'governance.html': 3, 'philanthropy.html': 1, 'philanthropy': 2, 'philanthropic': 1, 'engagement.html': 1, 'resources.html': 1, 'sustainability.html': 2, 'action': 1, 'report.pdf': 1, 'rebuilds': 1, 'north': 1, 'chicagos': 1, 'middle': 1, 'school': 1, 'inspiring': 1, 'reach': 1, 'higher.html': 1, 'news.abbvie.com': 11, 'fact': 4, 'pr': 2, 'investors.abbvie.com': 10, 'upcoming': 3, 'www.abbviecontractmfg.com': 3, 'www.abbviemedinfo.com': 3, 'AbbVieGlobal': 3, '?hl=en': 3, 'AbbVie': 3, 'algeria.html': 2, 'south': 2, 'africa.html': 2, 'tunisia.html': 2, 'www.abbvie.com.au': 2, 'www.abbvie.com.cn': 2, 'www.abbvie.com.hk': 2, 'www.abbvie.co.jp': 2, 'www.abbvie.co.kr': 2, 'www.abbvie.com.my': 2, 'www.abbvie.co.nz': 2, 'www.abbvie.com.sg': 2, 'www.abbvie.com.tw': 2, 'www.abbvie.at': 2, 'www.abbvie.be': 4, '?trackingSelection=Yes': 2, 'index.html?trackingSelection=Yes': 2, 'bosnia': 2, 'herzegovina.html': 2, 'www.abbvie.bg': 2, 'croatia.html': 2, 'www.abbvie.cz': 2, 'www.abbvie.dk': 2, 'www.abbvie.fi': 2, 'www.abbvie.fr': 2, 'www.abbvie.de': 2, 'www.abbvie.gr': 2, 'www.abbvie.hu': 2, 'www.abbvie.ie': 2, 'www.abbvie.it': 2, 'www.abbvie.nl': 2, 'www.abbvie.no': 2, 'www.abbvie.pl': 2, 'www.abbvie.pt': 2, 'romania.html': 2, 'www.abbvie.ru': 2, 'serbia.html': 2, 'www.abbvie.sk': 2, 'slovenia.html': 2, 'www.abbvie.es': 2, 'www.abbvie.se': 2, 'www.abbvie.ch': 4, 'fr.html': 4, 'www.abbvie.com.tr': 2, 'www.abbvie.ua': 2, 'www.abbvie.co.uk': 2, 'www.abbvie.com.mx': 2, 'www.abbvie.pr': 2, 'www.abbvie.co.il': 2, 'lebanon.html': 2, 'saudi': 2, 'arabia.html': 2, 'arab': 2, 'emirates.html': 2, 'www.abbvie.ca': 4, 'states.html': 2, 'www.abbvie.com.ar': 2, 'www.abbvie.com.br': 2, 'www.abbvie.cl': 2, 'www.abbvie.com.co': 2, 'www.abbvie.com.uy': 2, '#section01': 4, 'capsida': 1, 'biotherapeutics': 1, 'expand': 1, 'strategic': 2, 'collaboration': 2, 'targeted': 1, 'genetic': 1, 'high': 1, 'need.htm': 1, 'declares': 1, '1': 12, '2': 8, '3': 9, '4': 1, '6': 1, '9': 1, '13': 1, '14': 1, '15': 1, '16': 1, '17': 1, '18': 1, '21.htm': 1, 'results.htm': 1, 'represented': 1, 'ratings': 1, 'sheet.htm': 1, 'earnings.html': 1, 'proxy': 1, 'stewardship.pdf': 1, 'cobc': 1, 'cobc_English.pdf': 1, 'privacy.abbvie': 1, 'use.html': 1, 'site': 4, 'map.html': 1, 'www.jazzpharma.com': 115, 'wistia.com': 3, 'jazz': 8, 'pharmaceuticals?trk=company_logo': 1, 'jazzpharma?lang=en': 1, 'footprint': 13, 'zealand': 1, 'benelux': 1, 'nordic': 1, 'region': 1, 'countries': 1, 'supplied': 1, 'villa': 1, 'guardia': 1, 'gentium': 1, 'r': 1, 'l': 1, 'athlone': 1, 'pharmaceuticals': 9, 'limited': 1, 'outside': 2, 'non': 2, 'interventional': 1, 'gw': 1, 'cannabinoid': 1, 'platform': 4, 'sharing': 2, 'wp': 2, 'uploads': 2, 'JAZZ': 2, 'ESG': 2, 'Report.pdf': 2, 'education': 3, 'fellowships': 1, 'transfers': 2, 'investor.jazzpharma.com': 33, 'release': 20, 'email': 3, 'alerts': 3, 'document': 2, 'coverage': 9, 'careers.jazzpharma.com': 2, 'elevating': 1, 'voice': 1, 'epilepsy': 1, 'aes': 1, 'patient_stories': 1, 'shining': 1, 'light': 1, 'importance': 1, 'caregiving': 1, 'zymeworks': 2, 'announce': 2, '84': 1, 'overall': 1, 'survival': 1, '41st': 3, 'jp': 3, 'morgan': 3, 'has': 1, 'confirmed': 1, 'gaap': 2, 'reconciliations': 1, 'mailto:privacy@jazzpharma.com': 1, 'www.prothena.com': 97, '#management': 3, '#directors': 3, '#partnering': 3, '#our': 3, 'birtamimab': 3, 'attr': 3, 'amyloidosis': 3, 'pioneering': 8, '#publications': 3, '#birtamimab': 3, 'phase': 26, '#prasinezumab': 3, '#prx004': 3, '#prx005': 3, '#prx012': 3, '#expanded': 3, 'ir.prothena.com': 25, '#our_values': 3, '#comp_benefits': 3, '#opportunities': 3, 'house': 3, '#top': 2, 'www.roivant.com': 27, 'investor.roivant.com': 21, 'quote': 2, 'roivant': 3, 'inc': 1, 'dermavant.com': 1, 'www.immunovant.com': 1, 'www.genevant.com': 1, 'themes': 1, 'custom': 1, 'images': 1, 'documents': 2, 'Form8937.pdf': 1, 'polarisqb.com': 30, 'tachyon': 2, 'qmmm': 2, 'quantum': 4, 'computing': 2, 'artificial': 2, 'intelligence': 2, 'machine': 2, 'lead': 2, 'prediction': 1, 'cadd': 1, 'libraries': 1, 'allosteric': 1, 'bioscience': 1, 'phoremost': 1, 'auransa': 1, 'cloud': 1, 'fujitsu': 1, 'polaris': 4, 'polarisqb': 20, 'talks': 1, 'qubites': 1, 'valorem': 1, 'reply': 1, 'real': 1, 'ars': 1, 'technica': 1, 'writes': 1, 'd': 1, 'wave': 1, 'hackathons': 1, 'status': 6, '1624120011953405995': 2, 'Tachyon': 1, 'ArtificialIntelligence': 1, 'MachineLearning': 1, 'drugdiscovery': 2, 'intent': 9, 'tweet?in_reply_to=1624120011953405995&related=polarisqb': 1, 'retweet?tweet_id=1624120011953405995&related=polarisqb': 1, 'like?tweet_id=1624120011953405995&related=polarisqb': 1, '1623019510952300578': 2, 'quantumcomputing': 1, 'tweet?in_reply_to=1623019510952300578&related=polarisqb': 1, 'retweet?tweet_id=1623019510952300578&related=polarisqb': 1, 'like?tweet_id=1623019510952300578&related=polarisqb': 1, '1621557627858862081': 2, 'quantumcomputer': 1, 'tweet?in_reply_to=1621557627858862081&related=polarisqb': 1, 'retweet?tweet_id=1621557627858862081&related=polarisqb': 1, 'like?tweet_id=1621557627858862081&related=polarisqb': 1, 'mailto:info@polarisqb.com': 1, 'www.polarisqb.com': 1, '#contact': 1, 'www.ourcrowd.com': 1, 'myportfolio': 1, 'biotech': 3, 'www.maxbiopharma.com': 36, 'advisors': 4, 'oxysterol': 2, 'small': 1, 'molecules': 1, 'primary': 1, 'oxy133': 1, 'oxy210': 4, 'publications': 7, 'recent': 1, 'fcoi': 1, 'max': 8, 'attend': 1, 'biocoms': 1, 'inhibition': 1, 'profibrotic': 1, 'signaling': 1, 'effects': 1, 'its': 5, 'candidate': 6, 'receives': 4, 'direct': 1, 'ii': 1, 'award': 2, 'national': 1, 'publishes': 3, 'nash': 2, 'discoveries': 1, 'regarding': 1, 'candidates': 1, 'targeting': 1, 'nih': 1, 'sbir': 1, 'i': 1, 'update': 6, 'liver': 1, 'fibrosis': 1, 'is': 1, 'pursuing': 1, 'series': 1, 'financing': 1, '?page_id=50': 1, '?page_id=590': 1, '?page_id=322': 1, 'www.lexpharma.com': 44, 'map': 3, '833': 2, 'analyses': 2, 'sotagliflozin': 2, 'be': 2, 'presented': 4, 'college': 2, 'cardiology': 4, '72nd': 2, 'session': 2, 'federation': 2, 'congress': 2, '832': 2, 'lexicon': 8, 'participate': 4, '831': 2, 'topline': 2, 'proof': 2, 'concept': 2, 'lx9211': 4, 'postherpetic': 2, 'neuralgia': 2, '830': 2, '34th': 2, 'piper': 2, 'sandler': 2, '5th': 2, 'evercore': 2, 'isi': 2, 'healthconx': 2, '829': 2, 'shows': 5, 'significant': 2, 'consistent': 2, 'benefits': 2, 'painful': 2, 'diabetic': 2, 'neuropathy': 2, 'dpn': 2, '16th': 2, 'pain': 2, 'therapeutics': 4, 'summit': 2, 'Lexicon': 1, 'Pharmaceuticals': 1, 'Inc': 1, '1658524937805248': 1, 'LexPharma': 1, '10186': 1, 'finance': 1, 'purchasing.pdf': 1, 'www.asceneuron.com': 63, 'oga': 3, 'inhibitors': 1, 'progressive': 4, 'supranuclear': 4, 'palsy': 4, 'psp': 6, 'dementia': 9, 'lewy': 3, 'body': 3, 'ferrer': 2, 'acquires': 2, 'asn90': 4, 'exclusively': 2, 'treat': 2, 'asceneuron': 13, 'europe': 2, 'forum': 2, 'latsis': 2, 'symposium': 4, 'meet': 2, 'asbmb': 2, 'biology': 2, 'awarded': 2, 'grant': 4, 'j': 4, 'fox': 4, 'preclinical': 2, '2nd': 2, 'brainfit4life': 2, 'provide': 2, 'o': 2, 'glcnacase': 2, 'sa': 1, 'asceneuron_sa': 1, 'www.google.ch': 1, '@46.517753,6.561869': 1, 'node': 2, '25': 2, 'www.denalitherapeutics.com': 52, 'dnli.zoom.us': 1, 'rec': 1, 'v8_WCVA0KpkDjteSZIqjB0kerFnrTUzigmuRLmWh5JafCRowVSwJCLLb9FEYWs1X.jCueMcSKMWlBxUsx': 1, 'pathway': 1, 'biomarker': 1, 'careers#jobOpenings': 1, 'stem': 1, 'www.acimmune.com': 50, 'ir.acimmune.com': 40, 'figures': 1, 'milestones': 1, 'faq': 1, 'ir': 2, 'ac': 15, 'molecular': 5, 'imaging': 5, 'initiates': 5, 'immunes': 7, 'aci': 7, '35030': 4, 'AC_Immune_SA': 3, 'feed': 2, 'urn:li:activity:7003690821661171713': 2, 'offers': 1, 'road': 1, 'tackling': 1, 'heres': 1, '24060': 3, 'amyloid': 3, 'beta': 3, 'continued': 2, 'tel:+41213459121': 1, 'mailto:info@acimmune.com': 1, 'www.procab.ch': 1, 'creation': 1, 'geneve': 1, 'www.cookieyes.com': 1, 'ribontx.com': 49, 'cellular': 2, 'stress': 2, 'beacon': 3, 'nad': 2, 'utilizing': 2, 'enzymes': 2, 'rbn': 5, '2397': 3, '3143': 2, 'ribon': 2, 'RibonTx': 1}